London, UK, 21st September 2021 / Sciad Newswire / Life Science Integrates (LSI) is delighted to announce its inaugural PharmaTech Integrates Conference, to be hosted in partnership with the Medicines Manufacturing Innovation Centre on Thursday 23rd September 2021.
The past few years have seen exceptional innovation and growth across both the pharmaceutical industry and the technology sector. The rapid exchange of ideas between the leading pharmaceutical experts and the innovators driving advances in manufacturing technologies is essential for continued fast-paced advances in healthcare.
This one-day live online event will explore the challenges and opportunities pharmaceutical technology and digital tools offer. Our expert panel discussions, technology showcases and networking opportunities will centre around three core themes:
- Platform Technology: we’ll address stepping up Biologics production to meet patient needs, increasing the adoption of continuous manufacturing, and delivering improved control, efficiency and compliance of medicines manufacture whilst reducing the carbon footprint
- Novel Therapies: with discussion on transforming vaccine manufacture processes, progressing DNA and RNA based technologies for new therapeutic areas, and developing ATMP to address rare and complex diseases
- Advanced Digital Solutions: covering acceleration of drug development through digital applications, deployment of digital and data-driven approaches that enable demand-led pharmaceutical supply, and contextualisation of data and modelling to deliver real time decision making
Bringing together the leading 300+ experts in the fields of technology, diagnostics, devices, and therapeutics, as well as clinicians and regulators, the event promises exciting insights into the bright minds driving pharma-tech innovations.
With over 20 years of experience in technical, compliance and manufacturing leadership roles at high profile pharmaceutical companies, we are delighted to welcome Dave Tudor, MD of the Medicines Manufacturing Innovation Centre, to deliver the opening and closing talks.
“Innovation in novel medicines and the pharmaceutical supply chain is critical for adapting to the changing needs of global populations and driving a healthier society,” commented Dave. “That's why we're delighted to be a partner in the inaugural PharmaTech Integrates conference, which brings the wider pharmaceutical community together with the aim of educating the sector and collectively driving forward advances in disruptive technology.”
Dave’s opening and closing remarks will surround a packed day of interviews, panel discussions and workshops from influential scientists and managers across academia and industry including Professor Sir Jim McDonald, Principal and Vice-Chancellor of University of Strathclyde, and Juliette White, VP for Global SHE and Sustainability, AstraZeneca.
“Following the success of Pharma Integrates, MedTech Integrates and Bio Integrates, we are very excited to launch PharmaTech Integrates, targeting the crucial interdisciplinary crossover between the technology and pharmaceutical sectors,” comments LSI Co-Founder and Executive Director, Christopher Watt. “We have a high-profile line-up of 80+ expert speakers, and we’re particularly excited for our 11 technology showcases, new to our conferences, with leading institutions providing unique insights into cutting-edge technology advances that show the potential to revolutionize this field.”
For further information, contact:
Jo Stickings, Events & Marketing Manager
Life Science Integrates
Notes to Editors
About Life Science Integrates
Formed in 2011 by Christopher Watt and Samuel Thangiah, Life Science Integrates (LSI) brings together senior leaders from across the Life Sciences, including industry, academia, government, and regulators; providing them with unique opportunities to be part of the conversations that set out the industry’s challenges and identify effective strategies and solutions.